Jeddah Health Cluster Two signs a cooperation agreement with Jamjoom Pharma to enhance healthcare
Jeddah Health Cluster Two has signed a strategic cooperation agreement with Jamjoom Pharma, one of the most prominent Saudi companies specializing in the pharmaceutical industry. This partnership aims to enhance health awareness and develop professional capabilities within the medical sector in the Kingdom of Saudi Arabia.
This initiative comes within the framework of Jeddah Health Cluster Two's efforts to improve the quality of services provided to citizens and residents. Through collaboration with the private sector, the cluster seeks to exchange expertise and knowledge to ensure the provision of advanced healthcare that aligns with international standards.
The agreement will focus primarily on organizing specialized training programs for medical staff, in addition to launching awareness campaigns aimed at educating the community about the importance of disease prevention. This step will also contribute to supporting scientific research and developing innovative pharmaceutical solutions.
This partnership serves as a model for fruitful cooperation between government institutions and national companies, as it contributes to achieving the goals of Saudi Vision 2030 in developing the health sector. The results of this collaboration are expected to positively reflect on the efficiency of health services provided in the city of Jeddah and its surrounding areas.